Antibiotic Use in Aneurysm Repair

Introduction to Antibiotic Prophylaxis

The American Society of Anesthesiologists recommends antibiotic prophylaxis should be limited to the operative period only, with a maximum duration of 24 hours postoperatively for clean vascular surgery including aneurysm repair 1, 2, 3
Extending prophylaxis beyond 24 hours does not reduce infection risk and increases antibiotic resistance 4

The American College of Surgeons recommends cefazolin 2g IV as the first-line prophylactic antibiotic, administered 30-60 minutes before incision, with re-injection of 1g if surgery duration exceeds 4 hours 1, 2, 3, 5
Alternative cephalosporins include cefamandole or cefuroxime 1.5g IV, with re-injection of 0.75g if duration exceeds 2 hours 1, 2, 3
For beta-lactam allergy: vancomycin 30 mg/kg over 120 minutes (single dose) or clindamycin 900 mg IV 1, 3, 5

The American Heart Association recommends prolonged antibiotic therapy of 6 weeks to 6 months is recommended postoperatively for mycotic (infected) aneurysms, and in some cases lifelong suppressive therapy may be necessary 6
Broad-spectrum antibiotics targeting the identified organism should be used, with empiric coverage if cultures are negative 6

The European League Against Rheumatism recommends cyclosporine must be avoided in patients with Behçet's syndrome presenting with cerebral venous thrombosis or parenchymal nervous system involvement, as this condition can be associated with arterial aneurysms 7, 8
The American College of Cardiology advises against extending routine prophylactic antibiotics beyond 24 hours for non-infected aneurysm repairs, as this promotes resistance without benefit 1, 4

The European Society of Cardiology explicitly states that fluoroquinolones should generally be discouraged for patients with aortic aneurysms (both thoracic and abdominal), due to potential weakening of connective tissue and increased risk of aneurysm expansion or rupture 9
Fluoroquinolones may only be considered if there is a compelling clinical indication and absolutely no other reasonable alternative exists, as stated by the European Society of Cardiology 9
The mechanism of concern relates to potential weakening of connective tissue and increased risk of aneurysm expansion or rupture, though the guideline prioritizes avoidance as a precautionary measure, according to the European Society of Cardiology 9